Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Curtis Given

Neuroradiology Lexington, KY Medical Doctor

NPI 1699717751 CMS profile 212826

1760 Nicholasville Rd, Suite 301, Lexington, KY 40503

Open in the dashboard

General payments

$253,902

362 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$114,094 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Curtis Given of Lexington, KY is reported in the CMS Open Payments database as having received $253,902 across 362 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $114,094 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,600 19
2024 General $3,598 38
2023 General $4,709 39
2022 General $18,090 39
2021 General $53,001 69
2020 General $57,927 58
2019 General $114,977 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Curtis Given
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Curtis Given were reported at $1,600. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Curtis Given Neuroradiology median Middle half National median
2019 $114,977 $288 $71–$2,035 $163
2020 $57,927 $165 $32–$1,794 $114
2021 $53,001 $238 $42–$1,807 $132
2022 $18,090 $191 $49–$1,388 $149
2023 $4,709 $228 $56–$1,148 $160
2024 $3,598 $241 $97–$2,192 $164
2025 $1,600 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $119,813 174 payments
  2. Genentech USA, Inc. $55,472 31 payments
  3. Medtronic USA, Inc. $45,580 39 payments
  4. Medtronic, Inc. $24,517 91 payments
  5. Siemens Medical Solutions USA, Inc. $7,309 3 payments
  6. Scientia Vascular $318 1 payment
  7. Route 92 Medical, Inc. $166 1 payment
  8. Contego Medical, Inc $155 3 payments
  9. Alexion Pharmaceuticals, Inc. $108 1 payment
  10. MicroVention, Inc. $97 1 payment
  11. Other $367 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $105,410 39 payments
  2. Consulting Fee $103,455 31 payments
  3. Travel and Lodging $33,680 84 payments
  4. Food and Beverage $11,357 208 payments
Products named General payments · program years 2019–2025
  1. SURPASS $62,666 58 payments
  2. SURPASS EVOLVE $46,312 44 payments
  3. Activase $36,736 23 payments
  4. Pipeline Flow Diversion $34,533 29 payments
  5. Pipeline Flow Diversion $18,658 52 payments
  6. Covidien-Access $5,675 2 payments
  7. NEUROFORM ATLAS $4,444 4 payments
  8. SOLITAIRE X $3,183 29 payments
  9. TREVO $2,729 32 payments
  10. Solitaire $1,955 3 payments
  11. Other $9,611 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

119

Median for Diagnostic Radiology: 24

Drug cost

$15,313

Median for Diagnostic Radiology: $190

Branded share of claims

100%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 32 $14,894
Clopidogrel Clopidogrel Bisulfate Brand 87 $419

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$77,794

Medicare's payments for the services billed

Medicare patients

189

Average age 75

Services billed

490

101 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Ischemic heart disease 58%
Diabetes 45%
Chronic kidney disease 39%
COPD 32%
Heart failure 29%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

362 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record